247 related articles for article (PubMed ID: 15694656)
21. Novel promising linezolid analogues: rational design, synthesis and biological evaluation.
De Rosa M; Zanfardino A; Notomista E; Wichelhaus TA; Saturnino C; Varcamonti M; Soriente A
Eur J Med Chem; 2013 Nov; 69():779-85. PubMed ID: 24099997
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antibacterial activity of arylpiperazinyl oxazolidinones with diversification of the N-substituents.
Jang SY; Ha YH; Ko SW; Lee W; Lee J; Kim S; Kim YW; Lee WK; Ha HJ
Bioorg Med Chem Lett; 2004 Aug; 14(15):3881-3. PubMed ID: 15225689
[TBL] [Abstract][Full Text] [Related]
23. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
Ross JE; Fritsche TR; Sader HS; Jones RN
Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
[TBL] [Abstract][Full Text] [Related]
25. [Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Meng QG; Wang Q; Liu J
Yao Xue Xue Bao; 2003 Oct; 38(10):754-9. PubMed ID: 14730898
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antibacterial activity of potent heterocyclic oxazolidinones and the identification of RBx 8700.
Rudra S; Yadav A; Raja Rao AV; Srinivas AS; Pandya M; Bhateja P; Mathur T; Malhotra S; Rattan A; Salman M; Mehta A; Cliffe IA; Das B
Bioorg Med Chem Lett; 2007 Dec; 17(24):6714-9. PubMed ID: 17980588
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antibacterial activity of oxazolidinones containing triazolyl group.
Fan H; Xu G; Chen Y; Jiang Z; Zhang S; Yang Y; Ji R
Eur J Med Chem; 2007 Aug; 42(8):1137-43. PubMed ID: 17363116
[TBL] [Abstract][Full Text] [Related]
29. EUCAST Technical Note on linezolid.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
[No Abstract] [Full Text] [Related]
30. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
Foroumadi A; Emami S; Hassanzadeh A; Rajaee M; Sokhanvar K; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4488-92. PubMed ID: 16105736
[TBL] [Abstract][Full Text] [Related]
32. Oxazolidinone: search for highly potent antibacterial.
Lohray BB; Lohray VB; Srivastava BK; Gupta S; Solanki M; Kapadnis P; Takale V; Pandya P
Bioorg Med Chem Lett; 2004 Jun; 14(12):3139-42. PubMed ID: 15149661
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents.
Khera MK; Cliffe IA; Mathur T; Prakash O
Bioorg Med Chem Lett; 2011 May; 21(10):2887-9. PubMed ID: 21507643
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel oxazolidinone antimicrobial agents.
Ebner DC; Culhane JC; Winkelman TN; Haustein MD; Ditty JL; Ippoliti JT
Bioorg Med Chem; 2008 Mar; 16(5):2651-6. PubMed ID: 18077175
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antibacterial activities of novel oxazolidinones having cyclic sulfonamide moieties.
Kim SJ; Jung MH; Yoo KH; Cho JH; Oh CH
Bioorg Med Chem Lett; 2008 Nov; 18(21):5815-8. PubMed ID: 18842403
[TBL] [Abstract][Full Text] [Related]
36. Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubility.
Reck F; Zhou F; Eyermann CJ; Kern G; Carcanague D; Ioannidis G; Illingworth R; Poon G; Gravestock MB
J Med Chem; 2007 Oct; 50(20):4868-81. PubMed ID: 17722903
[TBL] [Abstract][Full Text] [Related]
37. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
Jones RN; Fritsche TR; Sader HS; Ross JE
Diagn Microbiol Infect Dis; 2007 Nov; 59(3):309-17. PubMed ID: 17720350
[TBL] [Abstract][Full Text] [Related]
38. The synthesis and antimicrobial evaluation of a new series of isoxazolinyl oxazolidinones.
Weidner-Wells MA; Werblood HM; Goldschmidt R; Bush K; Foleno BD; Hilliard JJ; Melton J; Wira E; Macielag MJ
Bioorg Med Chem Lett; 2004 Jun; 14(12):3069-72. PubMed ID: 15149646
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid.
D'Andrea S; Zheng ZB; Denbleyker K; Fung-Tomc JC; Yang H; Clark J; Taylor D; Bronson J
Bioorg Med Chem Lett; 2005 Jun; 15(11):2834-9. PubMed ID: 15911264
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
Anastasiou DM; Thorne GM; Luperchio SA; Alder JD
Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
